Found 24 matching trials
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. PHASE2 This study assessed pasireotide LAR efficacy on patients with non-functioni...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism PHASE2 To evaluate efficacy, safety, pharmacokinetics and pharmacodynamics of pasi...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) PHASE2 The goal of this clinical research study is to learn if the study drug, Pas...
Show More Location
Stanford Cancer Institute
Learn More & Join Trial
Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts PHASE3 Liver cysts are fluid filled cavities located in the liver. They are presen...
Show More Location
Radboud University Nijmegen Medical Center; Department of Gastroenterology & Hepatology
Learn More & Join Trial
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus PHASE2 Observe the safety/tolerability and effectiveness in terms of response rate...
Show More Location
Penn State Milton S. Hershey Medical Center
Learn More & Join Trial
Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors PHASE2 This is a phase II, open-label, 12-month pilot study in 10 patients with si...
Show More Location
Neuroendocrine Unit and Pituitary Center, Columbia University
Learn More & Join Trial
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET PHASE2 This study will estimate the treatment effect of everolimus in combination ...
Show More Location
Dana Farber Cancer Institute SC-2
Learn More & Join Trial
A Study of Pasireotide in People With Prolactinoma PHASE2 The researchers are doing this study to find out whether pasireotide is an ...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin PHASE2 This study will assess the effectiveness and safety of pasireotide long-act...
Show More Location
Cedars Sinai Medical Center Cedars Sinai 4
Learn More & Join Trial